60 likes | 206 Views
This piece explores key developments in the pharmaceutical industry including the market withdrawal of notable drugs like Vioxx and the significant price increase of Norvir by Abbott Laboratories. It highlights the substantial investments in drug development by companies like Merck and the challenges faced when patents expire. Additionally, it touches on upcoming events, including the Academy Awards, adding context to current cultural happenings. Stay informed about health and entertainment with insights into industry trends and award schedules.
E N D
1. Which of the following is true? • The FDA pulled Vioxx from the market • Merck shares are trading about $35 • Pfizer has pulled both Celebrex and Bextra from the market • Merck has several blockbuster drugs ready to release on the market
2. According to Raymond Gilmarten CEO of Merck • Merck spends about $3 billion a year on new drug development • When a drug goes off patent, you lose about 80 percent of the business in the first year • If you're a smaller company, you could be very well one or two drugs away from failure • All of these are true
3. According to the current event • Norvir is a drug for hypertension • Abbott Laboratories raised its price for an annual supply of Norvir from $1,600 to $7,800 • Norvir was found to be ineffective, had serious side effects and was pulled from the market • All of these are true
4. Which of the following is true • I will be having a Journal check next Thursday • Our second mid-term is scheduled for Tuesday March 21st at 8:00 a.m. • Both a and b are true
5. Which annual awards show where they hand out a golden “Oscar” will be held this Sunday? • The Academy Awards • The Grammys • The Tony Awards • The Espys